Ticker: FLAG

Calidi Biotherapeutics, Inc. (NYSEARCA: CLDI) has reported its quarterly financial results for the period ending March 31, 2025, revealing both advancements and ongoing challenges within the company. Key Financial Highlights: Net Loss: $5.062 million, showing an improvement from a net loss of $7...